The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas.
作者信息
Ostmeier H, Schumann J, Otto F, Krieg V, Fuchs B, Biess B, Burg G, Suter L
机构信息
Fachklinik Hornheide, Münster, FRG.
出版信息
J Cancer Res Clin Oncol. 1991;117(4):364-6. doi: 10.1007/BF01630721.
Abstract
Sex is a well proven prognosticator in primary malignant melanoma. We studied 19 parameters of tumor cells in primary malignant melanoma from 391 patients, the purpose being to determine if melanomas in men and women are alike. Apart from results in thin melanomas, no difference was seen between the sex groups. Thin melanomas showed a significant difference for the melanoma-associated antigen G7-E2 (higher expression in women) and the histocompatibility antigen HLA-DR (higher expression in men). The results suggest that sex-related prognostic differences are due more to host than to tumor characteristics.
摘要
相似文献
1
The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas.
J Cancer Res Clin Oncol. 1991;117(4):364-6. doi: 10.1007/BF01630721.
2
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
3
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Cochrane Database Syst Rev. 2015 May 16;2015(5):CD010307. doi: 10.1002/14651858.CD010307.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.
6
Neoadjuvant treatment for stage III and IV cutaneous melanoma.
Cochrane Database Syst Rev. 2023 Jan 17;1(1):CD012974. doi: 10.1002/14651858.CD012974.pub2.
7
Preoperative blood transfusions for sickle cell disease.
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
8
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
9
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.
Br J Dermatol. 2025 Jan 24;192(2):316-326. doi: 10.1093/bjd/ljae401.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
本文引用的文献
1
DNA aneuploidy in congenital melanocytic nevi: suggestive evidence for premalignant changes.
J Invest Dermatol. 1984 Jun;82(6):569-72. doi: 10.1111/1523-1747.ep12261301.
2
Low- and high-risk malignant melanoma--I. Evaluation of clinical and histological prognosticators in 585 cases.
Eur J Cancer Clin Oncol. 1983 Feb;19(2):227-35. doi: 10.1016/0277-5379(83)90421-2.
3
Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies.
Cancer Immunol Immunother. 1983;16(1):53-8. doi: 10.1007/BF00199906.
4
HLA-DR antigen expression in primary melanomas of the skin.
J Invest Dermatol. 1984 Mar;82(3):244-7. doi: 10.1111/1523-1747.ep12260181.
5
Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
Cancer Res. 1980 Jul;40(7):2523-8.
6
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.
Ann Surg. 1970 Nov;172(5):902-8. doi: 10.1097/00000658-197011000-00017.
7
In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89.
J Exp Med. 1985 Feb 1;161(2):366-77. doi: 10.1084/jem.161.2.366.
8
A tumor-associated antigen expressed in melanoma cells with lower malignant potential.
Int J Cancer. 1985 Jun 15;35(6):787-91. doi: 10.1002/ijc.2910350615.
9
Phenotypic dynamics of tumor progression in human malignant melanoma.
Int J Cancer. 1985 Jul 15;36(1):29-35. doi: 10.1002/ijc.2910360106.
Zotero 插件